Fri.May 27, 2022

article thumbnail

How to Increase Doctors’ Pharma Brand Loyalty

eMediWrite

With pharma brands competing more fiercely than ever before, the battle for physicians’ loyalty has intensified. Increasing client retention rates by just 5% can increase earnings by up to 95%. In a competitive market, it is critical for pharmaceutical companies to build brand loyalty among prescribers in order to stay on physicians’ thoughts.

Doctors 52
article thumbnail

4 tips to improve video feedback during MLR review

Vodori

Creating digital and video content is becoming a necessity for life sciences companies. . The pandemic has shaken the pharma sales channel and required companies to rethink their digital patient and HCP marketing strategies. A study from late 2020 says the pandemic accelerated pharma’s digital transformation two years in a two-month span. Healthcare providers and sales reps alike had to get word out under unprecedented constraints, and digital fit the bill.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

4th Extracellular Vesicle-Based Therapeutic Development Summit

pharmaphorum

Accelerating the Discovery, Translation & Large-Scale Manufacturing of Exosomes & EVs. With 3 days of unrivaled content and two dedicated tracks, this year’s summit will be putting the spotlight on cutting-edge strategies from discovery, translation, and clinical development of modified and unmodified exosomes and EVs, to accelerate this emerging field forward.

article thumbnail

Don’t blame mental health for mass murder

World of DTC Marketing

According to the National Institutes of Health, people with a mental health diagnosis committed less than 5 percent of gun-related homicides between 2001 and 2010. Mental health experts, including representatives from the American Psychological Association, have called it “unfounded” to blame mass shootings on mental illness in place of considering other possible factors, such as hate, bigotry, and access to assault weapons.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

13th World Multispecifics Summit

pharmaphorum

The 13 th Annual World Multispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field.

article thumbnail

The FDA now recommends that clinical trial sponsors submit a Race and Ethnicity Diversity Plan

Clarify Health

The FDA’s latest draft guidance on diversity and inclusion in clinical trials Diversity within the US continues to grow, with four in 10 Americans identifying with a race or ethnic group other than white. Racial and ethnic minorities face a disproportionate burden of diseases and are also frequently underrepresented in biomedical research and clinical trials.

FDA 52